When a metastatic brain tumor is diagnosed, it means that cancer cells from another organ have spread to the brain.
Metastatic tumors are the most common type of brain cancer today—about 10 times more common than cancers that originate within the brain (such as gliomas or meningiomas). The prevalence of brain metastases is increasing because cancer treatment has advanced considerably; instead of living just months after cancer diagnosis, many people live years with the disease, or their cancers go into remission. An estimated 200,000 new cases of brain metastases are now diagnosed in the U.S. every year.
Just a decade ago, finding a brain metastasis meant a person's average life expectancy was no more than six months, making aggressive treatment not worthwhile. That's no longer the case. With longer survival rates, neurosurgery is increasingly used to treat brain metastases.
Our dedicated team of oncologists and neurosurgeons focus specifically on the management of brain metastases. At Yale Medicine our world-renowned experts use state-of-the-art equipment to provide patients the best possible multidisciplinary care.